69 related articles for article (PubMed ID: 9300678)
21. Extinction of IL-12 signaling promotes Fas-mediated apoptosis of antigen-specific T cells.
Marth T; Zeitz M; Ludviksson BR; Strober W; Kelsall BL
J Immunol; 1999 Jun; 162(12):7233-40. PubMed ID: 10358170
[TBL] [Abstract][Full Text] [Related]
22. IL-12 drives IFN-gamma-dependent autoimmune kidney disease in MRL-Fas(lpr) mice.
Schwarting A; Tesch G; Kinoshita K; Maron R; Weiner HL; Kelley VR
J Immunol; 1999 Dec; 163(12):6884-91. PubMed ID: 10586090
[TBL] [Abstract][Full Text] [Related]
23. Leukocyte function-associated antigen-1-dependent lysis of Fas+ (CD95+/Apo-1+) innocent bystanders by antigen-specific CD8+ CTL.
Kojima H; Eshima K; Takayama H; Sitkovsky MV
J Immunol; 1997 Sep; 159(6):2728-34. PubMed ID: 9300693
[TBL] [Abstract][Full Text] [Related]
24. Recruitment of hepatic NK cells by IL-12 is dependent on IFN-gamma and VCAM-1 and is rapidly down-regulated by a mechanism involving T cells and expression of Fas.
Fogler WE; Volker K; Watanabe M; Wigginton JM; Roessler P; Brunda MJ; Ortaldo JR; Wiltrout RH
J Immunol; 1998 Dec; 161(11):6014-21. PubMed ID: 9834083
[TBL] [Abstract][Full Text] [Related]
25. Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma.
Choi C; Park JY; Lee J; Lim JH; Shin EC; Ahn YS; Kim CH; Kim SJ; Kim JD; Choi IS; Choi IH
J Immunol; 1999 Feb; 162(4):1889-95. PubMed ID: 9973455
[TBL] [Abstract][Full Text] [Related]
26. Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells.
Shimizu M; Fontana A; Takeda Y; Yagita H; Yoshimoto T; Matsuzawa A
J Immunol; 1999 Jun; 162(12):7350-7. PubMed ID: 10358186
[TBL] [Abstract][Full Text] [Related]
27. Differential capacities of CD4+, CD8+, and CD4-CD8- T cell subsets to express IL-18 receptor and produce IFN-gamma in response to IL-18.
Tomura M; Maruo S; Mu J; Zhou XY; Ahn HJ; Hamaoka T; Okamura H; Nakanishi K; Clark S; Kurimoto M; Fujiwara H
J Immunol; 1998 Apr; 160(8):3759-65. PubMed ID: 9558078
[TBL] [Abstract][Full Text] [Related]
28. Fas cross-linking mimics the inhibitory effect of anti-CD3 on IL-3-induced histamine and cytokine production by murine myeloid spleen cell precursors.
Ben Amor A; Schneider E; Arnould A; Machavoine F; Dy M
Exp Hematol; 1998 Aug; 26(9):903-9. PubMed ID: 9694512
[TBL] [Abstract][Full Text] [Related]
29. Impaired peripheral deletion of activated T cells in mice lacking the common cytokine receptor gamma-chain: defective Fas ligand expression in gamma-chain-deficient mice.
Nakajima H; Leonard WJ
J Immunol; 1997 Nov; 159(10):4737-44. PubMed ID: 9366397
[TBL] [Abstract][Full Text] [Related]
30. Different expression of Fas and Fas ligand in tumor infiltrating and peripheral lymphocytes of patients with renal cell carcinomas.
Elsässer-Beile U; Gierschner D; Welchner T; Wetterauer U
Anticancer Res; 2003; 23(1A):433-7. PubMed ID: 12680244
[TBL] [Abstract][Full Text] [Related]
31. Involvement of the Fas/Fas ligand pathway in activation-induced cell death of mycobacteria-reactive human gamma delta T cells: a mechanism for the loss of gamma delta T cells in patients with pulmonary tuberculosis.
Li B; Bassiri H; Rossman MD; Kramer P; Eyuboglu AF; Torres M; Sada E; Imir T; Carding SR
J Immunol; 1998 Aug; 161(3):1558-67. PubMed ID: 9686624
[TBL] [Abstract][Full Text] [Related]
32. CD30-regulated apoptosis in murine CD8 T cells after cessation of TCR signals.
Telford WG; Nam SY; Podack ER; Miller RA
Cell Immunol; 1997 Dec; 182(2):125-36. PubMed ID: 9514701
[TBL] [Abstract][Full Text] [Related]
33. Suppression of human B cell responsiveness by CD4+ T cells does not involve CD95-CD95 ligand interactions.
Hirohata S
Cell Immunol; 1997 Nov; 181(2):182-91. PubMed ID: 9398405
[TBL] [Abstract][Full Text] [Related]
34. A novel bystander effect involving tumor cell-derived Fas and FasL interactions following Ad.HSV-tk and Ad.mIL-12 gene therapies in experimental prostate cancer.
Hall SJ; Canfield SE; Yan Y; Hassen W; Selleck WA; Chen SH
Gene Ther; 2002 Apr; 9(8):511-7. PubMed ID: 11948376
[TBL] [Abstract][Full Text] [Related]
35. Fas-Fas ligand signaling pathway mediates an interleukin-12-induced rejection of a murine prostate tumor system.
Zhang S; Zeng G; Kao C; Gardner T; Sweeney C; Yang NS; Eble JN; Cheng L
Prostate; 2002 Sep; 53(1):69-76. PubMed ID: 12210482
[TBL] [Abstract][Full Text] [Related]
36. Interleukin (IL)-12 and IL-12 gene transfer up-regulate Fas expression in human osteosarcoma and breast cancer cells.
Lafleur EA; Jia SF; Worth LL; Zhou Z; Owen-Schaub LB; Kleinerman ES
Cancer Res; 2001 May; 61(10):4066-71. PubMed ID: 11358827
[TBL] [Abstract][Full Text] [Related]
37. Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells.
Zennadi R; Abdel-Wahab Z; Seigler HF; Darrow TL
Cell Immunol; 2001 Jun; 210(2):96-105. PubMed ID: 11520076
[TBL] [Abstract][Full Text] [Related]
38. Expression of the Fas ligand in cells of T cell lineage.
Suda T; Okazaki T; Naito Y; Yokota T; Arai N; Ozaki S; Nakao K; Nagata S
J Immunol; 1995 Apr; 154(8):3806-13. PubMed ID: 7706720
[TBL] [Abstract][Full Text] [Related]
39. Differential IL-12 responsiveness of T cells but not of NK cells from tumor-bearing mice in IL-12-responsive versus -unresponsive tumor models.
Iwasaki M; Yu WG; Uekusa Y; Nakajima C; Yang YF; Gao P; Wijesuriya R; Fujiwara H; Hamaoka T
Int Immunol; 2000 May; 12(5):701-9. PubMed ID: 10784616
[TBL] [Abstract][Full Text] [Related]
40. Cytolytic activity of murine IL-2-producing CD4+ and CD8+ T cell clones cycles in response to IL-2.
McKisic MD; Lancki DW; Cronin DC; Fitch FW
J Immunol; 1993 Oct; 151(8):4055-66. PubMed ID: 8409385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
